Acadia Healthcare Company, Inc. (ACHC) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-13

Key Insights

The reporting person, Brian Farley, acquired 37,510 shares of Acadia Healthcare Company, Inc. (ACHC) common stock at no cost, indicating an equity compensation award such as restricted stock units or stock options.
The award will vest over a 3-year period in equal yearly installments beginning April 10, 2027, aligning Farley's incentives with long-term shareholder value creation.
Insider buying can be a positive signal, as it suggests management's confidence in the company's prospects, though the size of the transaction is relatively small compared to Farley's existing stake of 106,675 shares.

Want the newest filings?

This analysis covers the filing from 2026-04-13. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-13

Todd S. Young, the Chief Financial Officer of Acadia Healthcare Company, Inc., has acquired 58,799 shares of the company's common stock, further aligning his interests with those of shareholders.
The shares acquired will vest over a 3-year period in equal yearly installments, indicating a long-term commitment from the CFO to the company's success.
Insider buying, especially by a C-suite executive, is generally seen as a positive signal for the company's future prospects and may boost investor confidence.

Filed: 2026-01-21

Debra K. Osteen, the Chief Executive Officer of Acadia Healthcare Company, Inc. (ACHC), has been granted a stock option to acquire 1,125,000 shares of the company's common stock, with vesting conditions tied to various stock price targets.
The vesting of the stock option is structured to incentivize Osteen to drive the company's stock price higher, with the first tranche of 250,000 shares vesting when the 30-day share price VWAP (volume-weighted average price) reaches $25.00, and subsequent tranches vesting at $35.00 and $45.00 share price targets.
The option grant reflects the company's commitment to aligning executive compensation with shareholder interests and long-term performance, as the vesting is dependent on the achievement of specific stock price milestones.

Other reports for Acadia Healthcare Company, Inc.

Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.